EXPOSED
The modal worker spends the day at the bench: accessioning and prepping specimens, loading and maintaining automated analyzers, reading peripheral smears and gram stains, troubleshooting flagged results, and running QC. Pattern-recognition tasks — differentials, urine sediment, microbiology plate reads, delta-check flagging — are exactly where digital imaging plus AI is landing first, and total lab automation lines already move tubes without hands. What holds is the physical, contamination-sensitive work (blood bank crossmatch, molecular setup, instrument repair) plus CLIA personnel standards and result validation that a certified human still signs.
Roughly flat across the period, with year-to-year wobble.
Median pay $53,120 → $62,930 -5.2% in real terms
This line is counted by the Bureau of Labor Statistics — the one figure on this page that isn't a judgement of ours. Headcount moves on demand, offshoring, demographics and the business cycle, and automation is one term among several, often not the loudest.
So a falling line is not evidence that AI did it, and a rising one is not evidence that it won't. Both happen in this register: some occupations resist automation and shrink anyway, others are highly automatable and keep growing. The marked year is 2020.
BLS projection, 2024–2034
+1.7% 351,200 → 357,200 on the projections basis
Growing, and only partly exposed
The BLS expects +1.7% more of these jobs by 2034, and at 49/100 the work is only partly exposed — some tasks are automatable, the core of the job is not. Nothing here is in tension.
Different clocks. The score is what current AI could do to this work today. The projection is how many of these jobs will exist in 2034. Everything between the two — how fast employers actually adopt, whether demand grows in the meantime — is why they can point opposite ways without either being wrong.
~22,600 openings a year on average, including replacing people who leave.
CytologistBlood TyperHistologistTechnologistBiotechnicianCytotechnicianHistologic AideHistotechnicianClinical ChemistCytotechnologistSleep TechnicianHistotechnologistLaboratory WorkerTissue TechnicianImmunohematologistMedical TechnicianSpecimen CollectorSpecimen ProcessorClinical ResearcherHistology AssistantSerology TechnicianTissue TechnologistVascular TechnicianCytology Coordinator
Holding it up: embodiment . Weakest point: trust premium .
Mixed — a routine tier and a judgment tier Roughly half the bench day is already machine-mediated — chemistry and hematology analyzers autoverify the bulk of CBCs and metabolic panels without a human touching the result — while the parts that hold out are manual differentials on flagged smears, plate reading and biochemical workups in micro, antibody identification panels in blood bank, and the judgment call when an instrument flags an interference or a delta check fails, which is why this sits at 11 rather than down at 6 with pure sample-in/answer-out testing.
Hands-on in uncontrolled environments Your hands are on biohazardous material all shift — decapping and aliquoting tubes, spinning and pouring off plasma, streaking plates in a BSC, pipetting molecular setup, doing tube-based crossmatches, plus dispensing probes, replacing lamps and clearing pipettor jams on the analyzers — but this all happens in a temperature-controlled, single-address room with fixed benches and known instrument layouts, not in a variable field environment.
Certification preferred, not legally required CLIA '88 personnel standards make your qualifications a condition of the lab's certificate and a dozen-odd states (CA, NY, FL, LA, among others) license clinical laboratory scientists personally, and you sign off validated results and QC records that surveyors read back to you — but the lab director and the ordering physician carry the ultimate legal exposure for the patient, so this lands at 9 rather than in nurse-or-pharmacist territory.
Meaningful discretion SOPs, package inserts and Westgard rules define most of what you do, but you decide whether to release or hold an implausible result, whether a QC failure invalidates the run, when to reject a specimen, when to call a pathologist for a smear, and how to resolve an antibody workup or an incompatible crossmatch on a bleeding patient — real discretion inside written procedure, hence 10 rather than 15.
The verdict above describes this occupation as a whole. Almost nobody does the typical version of a job — tick what's actually in your week and see how your own mix sits.
Your task mix speaks to task resistance (11/20 here) — how much of the day's work current AI already does. That is the dimension the boxes above are about.
It cannot move the other three. Liability shield (9/20) is whether the law requires a licensed human to sign. Trust premium (5/20) is whether buyers specifically pay for a person. Judgment and accountability (10/20) is whether the role exists to own consequential calls. Those are facts about the occupation's standing, not about which tasks are in your week — a paralegal who does only trial exhibits still holds no licence. Together they are 24 of this occupation's 49 points (49%).
Embodiment (14/20) is also a property of the work rather than the worker, but we don't tag individual tasks as physical or not, so the picker can't tell you anything about it. That's a limit of this tool, not a claim.
Did we get the list right? Tell us what's missing — the tasks are written from the outside, and you're reading this from the inside.
No occupation passed every test: close enough to clinical laboratory technologists and technicians on skills and subject matter, at least 10 points more resistant, no big jump in training, no new licence, no pay cut, and not shrinking on its own. That happens for 223 of the 654 occupations here that aren't SAFE, and it is worth stating plainly rather than leaving the section off.
The usual reason is that exposure travels with the skill profile. The jobs most similar to yours tend to be exposed for the same reasons yours is, so the near neighbours don't clear the gap — and the ones that do are a different kind of work, not a transfer of what you already know. Read that as a limit of this method, not a verdict that you're stuck: it only compares whole occupations, and it cannot see specialisation, industry, or anything you'd bring that isn't in a federal skill survey.
The moves above are yours to make. This is the other half: what would have to change in the world for the occupation itself to score higher. None of it is in any one person's gift, but it is where the floor actually comes from. Scores here are not a one-way ratchet. Only two of the five dimensions — task resistance and embodiment — track what machines can do. The other three track law, what buyers will pay for, and who is answerable, and those move in both directions, often in response to the same pressure AI creates. If every lever below landed, this occupation would score around 65/100, still EXPOSED.
Task-mix shift: this occupation genuinely has two tiers. If auto-verification middleware and digital morphology (Scopio, CellaVision, Techcyte) consume routine CBC differentials, urinalysis and normal plate reads, the residual role concentrates on blood bank antibody workups and incompatible crossmatch resolution, molecular assay setup and contamination control, analyzer troubleshooting, method validation and correlation studies, and QC/proficiency-testing failure investigation — work AI cannot do at usable quality. Headcount falls while per-worker resistance rises.
CAP Laboratory Accreditation Program checklist items (All Common / Hematology) adding a hard requirement that every AI-generated differential or plate read be verified by qualified personnel before reporting, with the verifier logged — this is enforceable at inspection and effectively makes the technologist the accountable signer.
CMS revision of CLIA '88 personnel and quality-system regulations (42 CFR 493) to explicitly name AI/computational pathology as a 'test system' requiring documented human validation, plus a named certified technologist (or CLIA-defined 'testing personnel') to release AI-flagged or AI-adjudicated results. The 2024 CLIA personnel rule update showed CMS is actively touching this section; FDA's evolving stance on Laboratory Developed Tests and on autonomous diagnostic software could force a countersignature requirement rather than an override-optional one.
Formal expansion of technologist authority in transfusion service and antimicrobial reporting — e.g., AABB Standards requiring a qualified individual to adjudicate crossmatch incompatibility and issue-under-emergency decisions, and CLSI M100-driven suppression/cascade reporting judgments — codified as named-person decisions rather than algorithm outputs.
No plausible upward route from regulation, but embodiment holds where specimen handling stays contamination-sensitive and non-standard: expansion of point-of-care and send-out molecular menus, plus manual pre-analytic work for tissue, bone marrow, body fluids and mislabeled/short-draw specimens, keeps hands in the loop. Total lab automation lines cover chemistry/hematology tubes, not these.
The limit. Trust premium has no realistic route: patients never choose or know their lab technologist, and buyers are hospitals and payers optimizing cost per test. Even a strong liability shield here protects the signature function, not headcount — one certified technologist can validate the output of a fully automated line, so scores can rise while employment falls.
| New York-Newark-Jersey City, NY-NJ | 16,220 | $96,930 +54% |
| Los Angeles-Long Beach-Anaheim, CA | 10,150 | $67,430 +7% |
| Dallas-Fort Worth-Arlington, TX | 9,420 | $59,280 -6% |
| Boston-Cambridge-Newton, MA-NH | 8,710 | $79,480 +26% |
| Chicago-Naperville-Elgin, IL-IN | 7,620 | $73,960 +18% |
| Miami-Fort Lauderdale-West Palm Beach, FL | 7,570 | $61,970 -2% |
| Houston-Pasadena-The Woodlands, TX | 7,410 | $61,350 -3% |
| Atlanta-Sandy Springs-Roswell, GA | 6,750 | $65,530 +4% |
| Kingston, NY | 60 | $103,180 +64% |
| Binghamton, NY | 130 | $102,040 +62% |
| Kiryas Joel-Poughkeepsie-Newburgh, NY | 340 | $98,290 +56% |
We have no reported case of a named organisation automating this occupation. Not one deployment, not one announcement.
That is worth saying out loud next to a score of 49. The verdict above is about what the work exposes — what current AI could do to these tasks. It is not a claim that anyone has done it. For this occupation those two things have come apart completely: the capability argument is on this page, and the evidence column is empty.
Has AI actually changed your work? One tap, anonymous, and the running tally is public. Nothing else is asked of you.
Rather than check back: get the digest and we'll tell you what changed — or watch a single occupation from its own page.